Diane Begemann

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Radical Prostatectomy

Top Venues

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Maddison Archer, Diane Begemann, Edgar G Kozlova, Prerna R Nepali, Estefanía Labanca, Peter D A Shepherd, Navneet Dogra, Nora M Navone, Natasha Kyprianou
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Molecular cancer research : MCR (2024)
Maddison Archer, Diane Begemann, Edgar G Kozlova, Prerna R Nepali, Estefanía Labanca, Peter D A Shepherd, Navneet Dogra, Nora M Navone, Natasha Kyprianou
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Molecular cancer research : MCR 22 (8) (2024)
Maddison Archer, Diane Begemann, Edgar G Kozlova, Prerna R Nepali, Estefanía Labanca, Peter D A Shepherd, Navneet Dogra, Nora M Navone, Natasha Kyprianou
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Molecular cancer research : MCR 22 (8) (2024)
Maddison Archer, Diane Begemann, Edgar G Kozlova, Prerna R Nepali, Estefanía Labanca, Peter D A Shepherd, Navneet Dogra, Nora M Navone, Natasha Kyprianou
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Molecular cancer research : MCR 22 (8) (2024)
Maddison Archer, Diane Begemann, Edgar G Kozlova, Prerna R Nepali, Estefanía Labanca, Peter D A Shepherd, Navneet Dogra, Nora M Navone, Natasha Kyprianou
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Molecular cancer research : MCR 22 (8) (2024)
Maddison Archer, Diane Begemann, Edgar G Kozlova, Prerna R Nepali, Estefanía Labanca, Peter D A Shepherd, Navneet Dogra, Nora M Navone, Natasha Kyprianou
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Molecular cancer research : MCR 22 (8) (2024)